Seven Eight Capital’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q1 | – | Sell |
-30,297
| Closed | -$2.57M | – | 647 |
|
2018
Q4 | $2.57M | Buy |
+30,297
| New | +$2.57M | 0.14% | 195 |
|
2018
Q3 | – | Sell |
-2,084
| Closed | -$269K | – | 641 |
|
2018
Q2 | $269K | Buy |
+2,084
| New | +$269K | 0.02% | 418 |
|
2017
Q4 | – | Sell |
-2,405
| Closed | -$204K | – | 522 |
|
2017
Q3 | $204K | Buy |
+2,405
| New | +$204K | 0.02% | 418 |
|